Pseudo-UTP, AOF

sodium salt, 100 mM, solution

Use left and right arrow keys to scroll between the tabs

A clean start in mRNA synthesis

Modified ribonucleotides enhance the expression and reduce the immunogenicity of mRNA. They are key to the success of therapeutic or vaccine mRNA.

Partially or completely replace UTP with this modified UTP to enhance the performance of modified mRNA. A fit-for-purpose reagent to manufacture mRNA for therapeutics and vaccines, Roche CustomBiotech Pseudo-UTP provides the performance, quality, and scale you need.

We have designed our manufacturing process from the master cell bank to final QC-release to exclude or minimize potential contaminants, thereby reducing overall process risk and simplifying procedures for regulatory approval.

Reach out to your regional representative for a quote or sample
Contact us

Ordering Information

Technical documents

for certificates, method sheets (instructions for use), safety data sheets and software downloads
error errorMessage
Sorry, we couldn't find the content you are looking for
Please try again later

Contact us

Looking to advance your biotech projects? Contact us now for more information, inquiries, or to discuss collaboration opportunities.